Cassava Sciences' stock is highly shorted, with potential reward tied to the upcoming Phase 3 trial results for simufilam.

If you want to know what to expect from the Nintendo Switch 2 then we're here to help. We've rounded-up all the latest rumours on Nintendo's next console, including leaks on the Switch 2 release ...